中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
22期
9-11
,共3页
袁跃龙%侯明英%向琳%谢辉%刘静%侯云菊%谢远容%杨萍%李峙澄
袁躍龍%侯明英%嚮琳%謝輝%劉靜%侯雲菊%謝遠容%楊萍%李峙澄
원약룡%후명영%향림%사휘%류정%후운국%사원용%양평%리치징
体外反搏%冠心病%慢性稳定型心绞痛
體外反搏%冠心病%慢性穩定型心絞痛
체외반박%관심병%만성은정형심교통
Enhanced external counter-pulsation%Coronary disease%Chronic stable angina
目的:研究短疗程体外反搏与长疗程体外反搏治疗慢性稳定型心绞痛的疗效。方法:将287例慢性稳定型心绞痛患者随机分为对照组(Ⅰ组n=95)、短疗程体外反搏治疗组(Ⅱ组n=97)、长疗程体外反搏治疗组(Ⅲ组n=95),随访时间为三个月,比较三组治疗后的心绞痛缓解率、心绞痛分级、SF-36评分。结果:随访结束时,心绞痛患者治疗的有效率分别为:Ⅰ组80.00%、Ⅱ组91.75%、Ⅲ组94.74%;Ⅱ组与Ⅲ组在心绞痛缓解率、心绞痛分级、SF-36评分等指标上明显优于Ⅰ组(P<0.05);但Ⅱ组与Ⅲ组组间比较差异无统计学意义(P>0.05)。结论:短疗程与长疗程体外反搏在治疗慢性稳定型心绞痛疗效相近,且均优于单纯药物治疗。
目的:研究短療程體外反搏與長療程體外反搏治療慢性穩定型心絞痛的療效。方法:將287例慢性穩定型心絞痛患者隨機分為對照組(Ⅰ組n=95)、短療程體外反搏治療組(Ⅱ組n=97)、長療程體外反搏治療組(Ⅲ組n=95),隨訪時間為三箇月,比較三組治療後的心絞痛緩解率、心絞痛分級、SF-36評分。結果:隨訪結束時,心絞痛患者治療的有效率分彆為:Ⅰ組80.00%、Ⅱ組91.75%、Ⅲ組94.74%;Ⅱ組與Ⅲ組在心絞痛緩解率、心絞痛分級、SF-36評分等指標上明顯優于Ⅰ組(P<0.05);但Ⅱ組與Ⅲ組組間比較差異無統計學意義(P>0.05)。結論:短療程與長療程體外反搏在治療慢性穩定型心絞痛療效相近,且均優于單純藥物治療。
목적:연구단료정체외반박여장료정체외반박치료만성은정형심교통적료효。방법:장287례만성은정형심교통환자수궤분위대조조(Ⅰ조n=95)、단료정체외반박치료조(Ⅱ조n=97)、장료정체외반박치료조(Ⅲ조n=95),수방시간위삼개월,비교삼조치료후적심교통완해솔、심교통분급、SF-36평분。결과:수방결속시,심교통환자치료적유효솔분별위:Ⅰ조80.00%、Ⅱ조91.75%、Ⅲ조94.74%;Ⅱ조여Ⅲ조재심교통완해솔、심교통분급、SF-36평분등지표상명현우우Ⅰ조(P<0.05);단Ⅱ조여Ⅲ조조간비교차이무통계학의의(P>0.05)。결론:단료정여장료정체외반박재치료만성은정형심교통료효상근,차균우우단순약물치료。
Objective:To research the efficacy of treating chronic stable angina by short-term enhanced external counter-pulsation and long-term enhanced external counter-pulsation.Method:The 289 chronic stable angina patients were randomly assigned to the control group(group one n=95),the short-term treatment group by enhanced external counter-pulsation(group two n=97)and the long-term treatment group by enhanced external counter-pulsation(group three n=95). The follow-up period was 3 months. Then the rate of angina relief,the endpoint of angina scores and SF-36 score were compared after the treatment.Result:In the end of follow-up,the effective rate of group one,group two and group three were 80.00%,91.75%,94.74%respectively. Group two and group three were superior to group one in the indicators such as the rate of angina relief,the endpoint of angina scores and SF-36 score(P<0.05),but there was no significant difference between group two and group three(P>0.05).Conclusion:There is no difference in treating chronic stable angina between the short-term and long-term enhanced external counter-pulsation,which are superior to drug therapy.